Effects of naloxone infusions in patients with the pruritus of cholestasis

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of The American Academy of Dermatology

• Publication date

  1996-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0190-9622(96)80127-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

  2018cites this paper
• Therapeutics for Pruritus in Cholestatic Liver Disease: Many Treatments but Few Cures

  2018cites this paper
• Jaundice associated pruritis: a review of pathophysiology and treatment.

  2015cites this paper
• Drug Information Rounds

  2015cites this paper
• Methylnaltrexone to Palliate Pruritus in Terminal Hepatic Disease

  2015cites this paper
• Symptomatic Management and Palliation

  2014cites this paper
• Treatment of refractory vulvovaginal pruritus with naltrexone, a specific opiate antagonist.

  2014cites this paper
• Therapie der Prurigo nodularis

  2014cites this paper
• Opioid antagonists.

  2014cites this paper
• Care of the cholestatic patient.

  2013cites this paper
• Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice

  2013cites this paper
• Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy

  2013cites this paper
• Opiate Receptor Antagonists for Treatment of Severe Pruritus Associated with Advanced Cholestatic Liver Disease

  2013cites this paper
• Involvement of Serine Protease and Proteinase-Activated Receptor 2 in Dermatophyte-Associated Itch in Mice

  2012cites this paper
• European S2k Guideline on Chronic Pruritus.

  2012cites this paper
• Pruritus in chronic cholestatic liver disease.

  2012cites this paper
• Primary sclerosing cholangitis: etiopathogenesis and clinical management.

  2012cites this paper
• Pathophysiology and current management of pruritus in liver disease.

  2011cites this paper
• The itch of liver disease.

  2011cites this paper
• Lysophosphatidic acid is a potential mediator of cholestatic pruritus.

  2010cites this paper
• Treatment options for primary sclerosing cholangitis

  2010cites this paper
• Innovative management of pruritus.

  2010cites this paper
• Anticonvulsants for the Treatment of Pruritus

  2010cites this paper
• Pruritus in Patients with Hepatobiliary Diseases

  2010cites this paper
• Management of autoimmune and cholestatic liver disorders.

  2009cites this paper
• Role of intravenous naloxone in severe pruritus of acute cholestasis

  2009cites this paper
• Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin.

  2009cites this paper
• Update on the treatment of the pruritus of cholestasis.

  2008cites this paper
• Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients.

  2008cites this paper
• Pruritus in primary biliary cirrhosis: pathogenesis and therapy.

  2008cites this paper
• Treatment of pruritus with topically applied opiate receptor antagonist.

  2007cites this paper
• The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated Pruritus

  2007cites this paper
• Intrahepatic Cholestasis of Pregnancy: Review of the Literature and Evaluation of Current Evidence

  2007cites this paper
• Sertraline as a first‐line treatment for cholestatic pruritus

  2007cites this paper
• Deletion of μ- and κ-Opioid Receptors in Mice Changes Epidermal Hypertrophy, Density of Peripheral Nerve Endings, and Itch Behavior

  2007cites this paper
• A new chronic itch model accompanied by skin lesions in hairless mice.

  2006cites this paper
• Effect of oral naltrexone on pruritus in cholestatic patients.

  2006cites this paper
• 5-hydroxytryptamine release in the anterior hypothalamic and the hippocampal areas of cholestatic rats.

  2006cites this paper
• A Review of the Evidence

  2005cites this paper
• 44 – Gender-Specific Issues in Liver Diseases

  2004cites this paper
• Further Studies on Aminopeptidase-M in Blood in Children with Cholestatic Liver Diseases and Viral Hepatitis

  2004cites this paper
• Opioids in the Management of Acute Pediatric Pain

  2003cites this paper
• Pruritus: a review.

  2003cites this paper
• Pain as a complication of use of opiate antagonists for symptom control in cholestasis.

  2003cites this paper
• Naloxone treatment of human hepatic encephalopathy

  2003cites this paper
• A Pilot Study to Compare Inhibitory Effects of Central Nervous System Drugs on Histamine-Induced Itch (Orinigal)

  2003cites this paper
• Itch: scratching more than the surface.

  2003cites this paper
• Intrahepatic Cholestasis of Pregnancy: Review of the Literature

  2002influential citation
• Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?

  2002cites this paper
• Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.

  2002cites this paper
• QJM Itch : scratching more than the surface

  2002cites this paper
• Drug Interactions with Patient-Controlled Analgesia

  2002cites this paper
• Pruritus in systemic disease: mechanisms and management.

  2002cites this paper
• O Prurido da Colestase

  2002cites this paper
• Neutral Endopeptidase Activity Is Not Elevated in Serum in Children with Cholestatic Liver Disease: A Unique Role of Aminopeptidase-M in Sequential Hydrolysis of Peptides

  2002cites this paper
• Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation.

  2002cites this paper
• Drug therapy of primary biliary diseases: classical and modern strategies

  2001cites this paper
• Pruritus in patients with chronic human immunodeficiency virus, hepatitis B and C virus infections.

  2000cites this paper
• Medical treatment of primary sclerosing cholangitis.

  1999cites this paper
• Opioid Antagonists in the Treatment of Pruritus from Cholestatic Liver Disease

  1998cites this paper
• Cholestatic liver diseases in adults

  1998cites this paper
• Dermatologic disorders associated with viral hepatitis

  1997cites this paper
• Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.

  1997cites this paper
• Hepatic inactivation of Leu-enkephalin.

  1996cites this paper
• The cutaneous manifestations of gastrointestinal disease.

  1996cites this paper
• The pruritus of cholestasis.

  1995cites this paper